Molecular characterization of tumors from a transgenic mouse adrenal tumor model: Comparison with human pheochromocytoma

International Journal of Oncology

Volumn 37, Issue 3, 2010, Pages 695-705

  Hattori, Yoshiyuki ^a   Kanamoto, Naotetsu ^b   Kawano, Kumi ^a   Iwakura, Hiroshi ^c   Sone, Masakatsu ^b   Miura, Masako ^b   Yasoda, Akihiro ^b   Tamura, Naohisa ^b   Arai, Hiroshi ^b   Akamizu, Takashi ^c   Nakao, Kazuwa ^b   Maitani, Yoshie ^a  

^a HOSHI UNIVERSITY   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adrenal tumor; DNA array; Neuroblastoma; Pheochromocytoma

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BETA3; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CHROMOGRANIN B; KINESIN 1; PHENYLETHANOLAMINE N METHYLTRANSFERASE;

ADRENAL NEUROBLASTOMA; ADRENAL TUMOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DNA MICROARRAY; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS;

ADRENAL GLAND NEOPLASMS; ANIMALS; ANTIGENS, POLYOMAVIRUS TRANSFORMING; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHEOCHROMOCYTOMA; RNA, MESSENGER; UP-REGULATION;

EID: 77956540750     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo_00000719     Document Type: Article

References (26)

1. Brodeur GM, Maris JM, Yamashiro DJ, Hogarty MD and White PS: Biology and genetics of human neuroblastomas. J Pediatr Hematol Oncol 19: 93-101, 1997.
2. Yamamoto K, Hanada R, Kikuchi A, et al: Spontaneous regression of localized neuroblastoma detected by mass screening. J Clin Oncol 16: 1265-1269, 1998.
3. Tischler AS: Pheochromocytoma and extra-adrenal paraganglioma: updates. Arch Pathol Lab Med 132: 1272-1284, 2008.
4. Adler JT, Meyer-Rochow GY, Chen H, et al: Pheochromocytoma: current approaches and future directions. Oncologist 13: 779-793, 2008.
5. Aguzzi A, Wagner EF, Williams RL and Courtneidge SA: Sympathetic hyperplasia and neuroblastomas in transgenic mice expressing polyoma middle T antigen. New Biol 2: 533-543, 1990. (Pubitemid 20316419)
6. Hammang JP, Baetge EE, Behringer RR, Brinster RL, Palmiter RD and Messing A: Immortalized retinal neurons derived from SV40 T-antigen-induced tumors in transgenic mice. Neuron 4: 775-782, 1990.
7. Helseth A, Siegal GP, Haug E and Bautch VL: Transgenic mice that develop pituitary tumors: a model for Cushing's disease. Am J Pathol 140: 1071-1080, 1992.
8. Suri C, Fung BP, Tischler AS and Chikaraishi DM: Catecholaminergic cell lines from the brain and adrenal glands of tyrosine hydroxylase-SV40 T antigen transgenic mice. J Neurosci 13: 1280-1291, 1993.
9. Fung KM, Chikaraishi DM, Suri C, et al: Molecular phenotype of simian virus 40 large T antigen-induced primitive neuroectodermal tumors in four different lines of transgenic mice. Lab Invest 70: 114-124, 1994.
10. Schulz N, Propst F, Rosenberg MM, et al: Patterns of neoplasia in c-mos transgenic mice and their relevance to multiple endocrine neoplasia. Henry Ford Hosp Med J 40: 307-311, 1992.
11. Schulz N, Propst F, Rosenberg MP, et al: Pheochromocytomas and C-cell thyroid neoplasms in transgenic c-mos mice: a model for the human multiple endocrine neoplasia type 2 syndrome. Cancer Res 52: 450-455, 1992.
12. Smith-Hicks CL, Sizer KC, Powers JF, Tischler AS and Costantini F: C-cell hyperplasia, pheochromocytoma and sympathoadrenal malformation in a mouse model of multiple endocrine neoplasia type 2B. EMBO J 19: 612-622, 2000.
13. Williams BO, Schmitt EM, Remington L, et al: Extensive contribution of Rb-deficient cells to adult chimeric mice with limited histopathological consequences. EMBO J 13: 4251-4259, 1994. (Pubitemid 24295197)
14. You MJ, Castrillon DH, Bastian BC, et al: Genetic analysis of Pten and Ink4a/Arf interactions in the suppression of tumorigenesis in mice. Proc Natl Acad Sci USA 99: 1455-1460, 2002.
15. Jacks T, Shih TS, Schmitt EM, Bronson RT, Bernards A and Weinberg RA: Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7: 353-361, 1994.
16. Iwakura H, Ariyasu H, Kanamoto N, et al: Establishment of a novel neuroblastoma mouse model. Int J Oncol 33: 1195-1199, 2008.
17. Hattori Y and Maitani Y: Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther 12: 796-809, 2005.
18. Wong DL: Why is the adrenal adrenergic? Endocr Pathol 14: 25-36, 2003.
19. Tischler AS, Freund R, Carroll J, et al: Polyoma-induced neoplasms of the mouse adrenal medulla. Characterization of the tumors and establishment of cell lines. Lab Invest 68: 541-549, 1993.
20. Cheung IY, Feng Y, Gerald W and Cheung NK: Exploiting gene expression profiling to identify novel minimal residual disease markers of neuroblastoma. Clin Cancer Res 14: 7020-7027, 2008.
21. Moreno-Sanchez R, Rodriguez-Enriquez S, Marin-Hernandez A and Saavedra E: Energy metabolism in tumor cells. FEBS J 274: 1393-1418, 2007.
22. Nakata H and Kozasa T: Functional characterization of Galphao signaling through G protein-regulated inducer of neurite outgrowth 1. Mol Pharmacol 67: 695-702, 2005. (Pubitemid 40365317)
23. Hedborg F, Ohlsson R, Sandstedt B, Grimelius L, Hoehner JC and Pahlman S: IGF2 expression is a marker for paragaglionic/SIF cell differentiation in neuroblastoma. Am J Pathol 146: 833-847, 1995.
24. Swerts K, De MB, Dhooge C, et al: Potential application of ELAVL4 real-time quantitative reverse transcription-PCR for detection of disseminated neuroblastoma cells. Clin Chem 52: 438-445, 2006.
25. Zhou J, Li J, Chen J, Liu Y, Gao W and Ding Y: Over-expression of CDH22 is associated with tumor progression in colorectal cancer. Tumour Biol 30: 130-140, 2009.
26. Deeb KK, Michalowska AM, Yoon CY, et al: Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res 67: 8065-8080, 2007.